XML 87 R77.htm IDEA: XBRL DOCUMENT v3.23.1
Note 16 - Stock-based Compensation (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Nov. 18, 2022
Nov. 01, 2022
Oct. 31, 2022
Oct. 01, 2021
Dec. 18, 2020
Sep. 07, 2018
Sep. 05, 2018
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Restricted Stock [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)               0    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)               1,146,947   1,146,947
Share-Based Payment Arrangement, Expense               $ 200 $ 200  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)               (0)    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance (in dollars per share)               $ 5.19   $ 5.19
A2018 Restricted Stock Awards [Member] | Restricted Stock [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)             500,000      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount               $ 400    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)               500,000    
Restricted Stock Awards 2021 [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)               646,947    
Restricted Stock Awards 2021 [Member] | Restricted Stock [Member] | Officer [Member]                    
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount               $ 2,800    
A2018 PWSC Restricted Stock Awards [Member] | Restricted Stock [Member] | Officer of PWSC [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)           1,000        
PWSC Restricted Stock Award 2020 [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)                   100,000
PWSC Restricted Stock Award 2020 [Member] | Restricted Stock [Member] | Officer of PWSC [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)         250          
A2020 Modified PWSC Restricted Stock Awards [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance (in shares)               0    
PWSC Restricted Stock Award [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)                   0
Ravix RUA 2021 [Member] | Restricted Common Unit Awards [Member] | Officer [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)       199,000            
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount               $ 300    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)               86,153   91,361
Share-Based Payment Arrangement, Expense               $ 100    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)   2 years 11 months 1 day 2 years 11 months 1 day 4 years            
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate   72.00% 58.00% 75.00%            
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   4.44% 4.44% 0.93%            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)       83,333       5,208    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance (in dollars per share)               $ 3.08    
Ravix RUA 2021 [Member] | Restricted Common Unit Awards [Member] | Officer [Member] | Maximum [Member]                    
Share-Based Payment Arrangement, Expense   $ 100                
SNS RUA [Member] | Restricted Common Unit Awards [Member] | Officer [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 75,000                  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount                   $ 300
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)               50,000   50,000
Share-Based Payment Arrangement, Expense               $ 100 $ 0  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year) 4 years                  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 85.00%                  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 4.09%                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares) 25,000             0    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance (in dollars per share) $ 5.95